Andean Precious Metals (CVE:APM) Trading 2.4% Higher – Should You Buy?

Shares of Andean Precious Metals Corp. (CVE:APM) traded up 2.4% during trading on Wednesday . The company traded as high as C$1.31 and last traded at C$1.30. 144,071 shares were traded during mid-day trading, a decline of 27% from the average session volume of 196,891 shares. The stock had previously closed at C$1.27.

Analyst Upgrades and Downgrades

Separately, Desjardins upgraded shares of Andean Precious Metals to a “moderate buy” rating in a report on Thursday, October 31st.

Andean Precious Metals Trading Up 2.4 %

The company has a market cap of C$194.17 million, a price-to-earnings ratio of 3.42 and a beta of 1.22. The firm’s 50-day moving average price is C$1.54 and its 200 day moving average price is C$1.21.

Insider Activity at Andean Precious Metals

In other Andean Precious Metals news, insider 2176423 Ontario Ltd. purchased 700,000 shares of Andean Precious Metals stock in a transaction that occurred on Tuesday, September 24th. The stock was acquired at an average price of C$1.36 per share, with a total value of C$952,000.00. In the last 90 days, insiders acquired 1,202,800 shares of company stock valued at $1,607,032. 69.37% of the stock is owned by company insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.